Overview Financials News + Filings Key Docs Ownership Insiders
|
| In millions, except per share items | Jun-30-23 | Mar-31-23 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 | Jun-30-21 | Mar-31-21 |
| | 10-Q | 8-K | 10-Q | 10-Q | 10-K | 10-K | 10-Q | 10-Q |
| Revenues: |
| Other | 0.2 | | 1.7 | | | | | |
| Product revenue | 2.9 | 1.2 | 0.7 | 0.5 | | | 0.5 | 0.2 |
| Assay services revenue | 16.6 | 18.4 | 10.9 | 18.8 | | | 16.2 | 14.6 |
| Other | 0.8 | 0.8 | 0.8 | 3.7 | | | 3.1 | 4.1 |
| Total revenues [+] | 20.5 | 20.4 | 14.1 | 23.0 | 23.0 | 20.0 | 19.8 | 18.9 |
| Royalties | | 14.1 | | | | | | |
| Products | | 1.2 | | | | | | |
| Revenue growth [+] | 44.7% | -11.3% | -28.5% | 21.8% | -18.5% | 40.5% | | |
| Other | -88.5% | | | | | | | |
| Product revenue | 307.4% | 161.8% | 54.5% | 134.7% | | | | |
| Assay services revenue | 51.8% | -2.0% | -32.7% | 29.0% | | | | |
| Cost of goods sold | 0.0 | 0.6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross profit | 20.5 | 19.7 | 14.1 | 23.0 | 23.0 | 20.0 | 19.8 | 18.9 |
| Gross margin | 100.0% | 96.9% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Selling, general and administrative [+] | 29.6 | 34.2 | 36.8 | 30.8 | 29.7 | 20.6 | 14.8 | 12.8 |
| General and administrative | | | | | 29.7 | | | |
| Research and development | 10.8 | | 17.6 | 13.8 | 11.2 | 15.6 | 8.6 | 8.1 |
| Other operating expenses | 11.2 | 25.7 | 7.1 | 11.7 | 10.5 | 8.8 | 8.0 | 6.2 |
| EBITDA [+] | -27.5 | | -46.4 | -32.5 | -27.7 | | -11.0 | -7.6 |
| EBITDA growth | -40.9% | 23.5% | 323.8% | 327.5% | -2771.0% | 323.8% | | |
| EBITDA margin | -134.1% | -197.2% | -328.2% | -141.6% | -120.5% | -125.1% | -55.4% | -40.3% |
| Depreciation and amortization | 3.6 | | 1.0 | 0.8 | 0.7 | | 0.7 | 0.7 |
| EBIT [+] | -31.1 | -40.2 | -47.4 | -33.3 | -28.4 | -25.0 | -11.6 | -8.3 |
| EBIT growth | -34.4% | 20.7% | 307.5% | 300.5% | -9778.5% | 323.8% | | |
| EBIT margin | -151.9% | -197.2% | -335.0% | -144.9% | -123.3% | -125.1% | -58.8% | -44.1% |
| Interest income, net [+] | 5.8 | | 0.8 | | | 0.0 | -0.1 | -1.2 |
| Interest expense | | | | | | 0.0 | 0.1 | 1.2 |
| Interest income | 5.8 | | 0.8 | | | | | |
| Other income (expense), net [+] | 0.5 | 6.0 | 23.6 | 29.3 | 5.1 | -16.4 | -1.6 | 0.0 |
| Gain (loss) on debt retirement | | | | | | -2.7 | -1.6 | |
| Gain (loss) on foreign currency transactions | | 0.0 | | | | | | |
| Change in fair value of warrants | 0.5 | | 14.5 | 12.6 | 1.2 | -8.1 | | |
| Change in value of contingent liability | | | | 16.5 | 3.8 | -5.7 | | |
| Pre-tax income | -24.8 | -34.2 | -23.0 | -4.0 | -23.3 | -41.4 | -13.3 | -9.5 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | | 0.0% | | 0.0% | | 0.0% | 0.0% | 0.0% |
| Net income | -24.8 | 0.0 | -23.0 | -4.0 | -23.3 | -41.4 | -13.3 | -9.5 |
| Net margin | -121.0% | 0.0% | -162.5% | -17.3% | -101.4% | -207.2% | -67.4% | -50.3% |
| |
| Basic EPS [+] | ($0.13) | $0.00 | ($0.13) | ($0.02) | ($0.17) | ($0.30) | ($0.12) | ($0.08) |
| Growth | 5.7% | -100.0% | 8.1% | -73.6% | 24.2% | 146.5% | | |
| Diluted EPS [+] | ($0.13) | $0.00 | ($0.13) | ($0.02) | ($0.17) | ($0.30) | ($0.12) | ($0.08) |
| Growth | 5.7% | -100.0% | 8.1% | -73.6% | 24.2% | 146.5% | | |
| |
| Shares outstanding (basic) [+] | 186.7 | 186,524.5 | 183.1 | 182.1 | 137.2 | 137.2 | 114.9 | 114.5 |
| Growth | 2.0% | 102357.6% | 59.4% | 59.0% | 110.5% | 124.5% | | |
| Shares outstanding (diluted) [+] | 186.7 | 186,524.5 | 183.1 | 182.1 | 137.2 | 137.2 | 114.9 | 114.5 |
| Growth | 2.0% | 102357.6% | 59.4% | 59.0% | 110.5% | 124.5% | | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|